Corrigendum to From Vision to Validation: The Journey of Tofersen in Superoxide Dismutase 1Gene–Associated Amyotrophic Lateral Sclerosis [Mayo Clinic Proceeding: Innovations, Quality & Outcomes 10(5) (2026) PIQO_100755]

Mayo Clinic Proceedings: Innovations, Quality & Outcomes · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles